RXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.75%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,756,205.46

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$5.63

▲ +0.215 (3.97%)

As of 04/22/2025 02:14 PM ET

Days: 30 | 90 | 365

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/13/2024	Michael Secora	CFO	Sell	15,000	$7.66	$114,900.00	1,499,631
11/12/2024	Blake Borgeson	Director	Sell	11,447	$7.64	$87,455.08	7,066,113
10/29/2024	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,077,560
10/24/2024	Tina Marriott	COO	Sell	6,000	$6.31	$37,860.00	521,138
10/15/2024	Blake Borgeson	Director	Sell	11,447	$6.67	$76,351.49	7,089,007
10/8/2024	Michael Secora	CFO	Sell	15,000	$6.32	$94,800.00	1,426,506
10/2/2024	Christopher Gibson	CEO	Sell	20,000	$6.16	$123,200.00	762,656
10/1/2024	Blake Borgeson	Director	Sell	11,447	$6.22	$71,200.34	7,098,428
9/26/2024	Tina Marriott	COO	Sell	6,000	$7.00	$42,000.00	521,138
9/17/2024	Blake Borgeson	Director	Sell	11,447	$6.84	$78,297.48	7,109,875
9/10/2024	Michael Secora	CFO	Sell	15,000	$6.17	$92,550.00	1,377,756
9/4/2024	Christopher Gibson	CEO	Sell	20,000	$6.04	$120,800.00	762,656
9/3/2024	Blake Borgeson	Director	Sell	11,447	$6.27	$71,772.69	7,121,322
8/29/2024	Tina Marriott	COO	Sell	6,000	$7.56	$45,360.00	521,138
8/20/2024	Blake Borgeson	Director	Sell	11,447	$7.12	$81,502.64	7,132,769
8/13/2024	Michael Secora	CFO	Sell	15,000	$6.35	$95,250.00	1,340,968
8/7/2024	Christopher Gibson	CEO	Sell	30,000	$7.10	$213,000.00	758,738
8/6/2024	Blake Borgeson	Director	Sell	11,447	$6.82	$78,068.54	7,144,216
7/25/2024	Tina Marriott	COO	Sell	6,000	$8.13	$48,780.00	535,457
7/23/2024	Blake Borgeson	Director	Sell	11,447	$8.48	$97,070.56	7,155,663
7/10/2024	Christopher Gibson	CEO	Sell	50,000	$7.48	$374,000.00	758,738
7/9/2024	Blake Borgeson	Director	Sell	11,447	$7.32	$83,792.04	7,167,110
7/9/2024	Michael Secora	CFO	Sell	15,000	$7.32	$109,800.00	1,292,218
6/27/2024	Tina Marriott	COO	Sell	6,000	$7.21	$43,260.00	535,457
6/25/2024	Blake Borgeson	Director	Sell	11,447	$9.51	$108,860.97	7,177,116
6/13/2024	Michael Secora	CFO	Sell	15,000	$9.32	$139,800.00	1,243,468
6/11/2024	Blake Borgeson	Director	Sell	11,447	$8.45	$96,727.15	7,188,563
6/5/2024	Christopher Gibson	CEO	Sell	50,000	$8.42	$421,000.00	758,738
5/30/2024	Tina Marriott	COO	Sell	3,000	$8.78	$26,340.00	535,457
5/28/2024	Blake Borgeson	Director	Sell	11,447	$9.17	$104,968.99	7,186,913
5/1/2024	Christopher Gibson	CEO	Sell	50,000	$7.73	$386,500.00	863,524
4/30/2024	Blake Borgeson	Director	Sell	11,447	$7.95	$91,003.65	7,218,414
4/25/2024	Tina Marriott	COO	Sell	3,000	$7.67	$23,010.00	543,231
4/17/2024	Michael Secora	CFO	Sell	23,124	$7.58	$175,279.92	1,231,055
4/16/2024	Blake Borgeson	Director	Sell	11,447	$7.66	$87,684.02	7,229,861
4/3/2024	Christopher Gibson	CEO	Sell	40,000	$8.84	$353,600.00	978,524
4/2/2024	Blake Borgeson	Director	Sell	11,447	$8.82	$100,962.54	7,241,308
3/28/2024	Christopher Gibson	CEO	Sell	40,000	$10.10	$404,000.00	1,043,524
3/21/2024	Tina Marriott	COO	Sell	8,000	$10.75	$86,000.00	639,982
3/19/2024	Blake Borgeson	Director	Sell	20,054	$10.79	$216,382.66	7,252,755
3/13/2024	Michael Secora	CFO	Sell	25,000	$11.03	$275,750.00	1,204,179
3/6/2024	Christopher Gibson	CEO	Sell	36,319	$11.86	$430,743.34	1,108,524
3/5/2024	Blake Borgeson	Director	Sell	20,054	$12.06	$241,851.24	7,272,809
2/22/2024	Tina Marriott	COO	Sell	8,000	$14.89	$119,120.00	639,982
2/20/2024	Blake Borgeson	Director	Sell	20,054	$12.32	$247,065.28	7,292,863
2/13/2024	Michael Secora	CFO	Sell	25,000	$9.86	$246,500.00	1,173,851
2/7/2024	Christopher Gibson	CEO	Sell	48,272	$9.22	$445,067.84	774,703
2/6/2024	Blake Borgeson	Director	Sell	11,447	$9.30	$106,457.10	7,312,917
1/25/2024	Tina Marriott Larson	COO	Sell	8,000	$10.35	$82,800.00	414,548
1/23/2024	Blake Borgeson	Director	Sell	20,054	$10.58	$212,171.32	7,324,364
1/16/2024	Michael Secora	CFO	Sell	25,000	$10.45	$261,250.00	968,514
1/16/2024	Shafique Virani	Insider	Sell	18,000	$10.93	$196,740.00	136,748
1/9/2024	Dean Y. Li	Director	Sell	29,000	$13.66	$396,140.00	421,000
1/3/2024	Christopher Gibson	CEO	Sell	30,853	$9.49	$292,794.97	791,725
12/26/2023	Blake Borgeson	Director	Sell	20,054	$10.63	$213,174.02	7,364,472
12/15/2023	Shafique Virani	Insider	Sell	18,000	$9.60	$172,800.00	136,748
12/14/2023	Zavain Dar	Director	Sell	20,141	$9.00	$181,269.00	53,823
12/12/2023	Blake Borgeson	Director	Sell	11,447	$7.40	$84,707.80	7,384,526
12/12/2023	Michael Secora	CFO	Sell	25,000	$7.39	$184,750.00	943,514
12/6/2023	Christopher Gibson	CEO	Sell	59,829	$7.49	$448,119.21	791,328
11/28/2023	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,395,973
11/16/2023	Tina Marriott Larson	COO	Sell	3,000	$6.76	$20,280.00	413,404
11/15/2023	Shafique Virani	Insider	Sell	18,000	$6.51	$117,180.00	140,351
11/14/2023	Blake Borgeson	Director	Sell	8,885	$6.32	$56,153.20	7,407,420
11/14/2023	Michael Secora	CFO	Sell	25,000	$6.32	$158,000.00	925,686
11/1/2023	Christopher Gibson	CEO	Sell	37,177	$5.20	$193,320.40	836,820
10/31/2023	Blake Borgeson	Director	Sell	8,885	$5.27	$46,823.95	7,416,305
10/26/2023	Tina Marriott Larson	COO	Sell	3,000	$5.63	$16,890.00	418,782
10/17/2023	Blake Borgeson	Director	Sell	8,885	$6.58	$58,463.30	7,425,190
10/16/2023	Shafique Virani	Insider	Sell	18,000	$6.30	$113,400.00	140,351
10/10/2023	Michael Secora	CFO	Sell	25,000	$7.07	$176,750.00	900,686
10/4/2023	Christopher Gibson	CEO	Sell	59,794	$7.21	$431,114.74	842,747
10/3/2023	Blake Borgeson	Director	Sell	8,885	$7.29	$64,771.65	7,434,075
9/28/2023	Tina Marriott Larson	COO	Sell	3,000	$7.72	$23,160.00	418,782
9/19/2023	Blake Borgeson	Director	Sell	8,885	$8.36	$74,278.60	7,442,960
9/15/2023	Shafique Virani	Insider	Sell	18,000	$8.66	$155,880.00	140,351
9/13/2023	Michael Secora	CFO	Sell	25,000	$8.69	$217,250.00	888,186
9/6/2023	Christopher Gibson	CEO	Sell	33,765	$8.78	$296,456.70	871,291
9/5/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,451,845
8/24/2023	Tina Marriott Larson	COO	Sell	3,000	$8.66	$25,980.00	418,782
8/22/2023	Blake Borgeson	Director	Sell	8,885	$8.91	$79,165.35	7,460,730
8/16/2023	Michael Secora	CFO	Sell	25,000	$8.90	$222,500.00	863,186
8/15/2023	Shafique Virani	Insider	Sell	18,000	$9.25	$166,500.00	140,351
8/8/2023	Blake Borgeson	Director	Sell	17,770	$11.16	$198,313.20	7,469,615
8/2/2023	Christopher Gibson	CEO	Sell	65,015	$13.04	$847,795.60	890,719
7/27/2023	Tina Marriott Larson	COO	Sell	8,000	$13.62	$108,960.00	424,160
7/26/2023	Shafique Virani	Insider	Sell	20,000	$14.41	$288,200.00	143,954
7/25/2023	Blake Borgeson	Director	Sell	18,719	$14.61	$273,484.59	7,487,385
7/18/2023	Michael Secora	CFO	Sell	25,000	$13.63	$340,750.00	830,413
7/17/2023	Shafique Virani	Insider	Sell	30,000	$11.72	$351,600.00	143,954
7/13/2023	Terry-Ann Burrell	Director	Sell	8,275	$12.59	$104,182.25	54,847
7/12/2023	Christopher Gibson	CEO	Sell	31,818	$13.14	$418,088.52	915,810
7/11/2023	Blake Borgeson	Director	Sell	8,885	$6.89	$61,217.65	7,520,104
6/29/2023	Tina Marriott Larson	COO	Sell	3,000	$7.49	$22,470.00	424,160
6/27/2023	Blake Borgeson	Director	Sell	8,885	$7.39	$65,660.15	7,528,989
6/13/2023	Blake Borgeson	Director	Sell	15,485	$9.98	$154,540.30	7,525,262
6/13/2023	Michael Secora	CFO	Sell	25,000	$9.93	$248,250.00	805,413
6/7/2023	Christopher Gibson	CEO	Sell	56,436	$9.05	$510,745.80	916,378
6/1/2023	Shafique Virani	Insider	Sell	25,000	$8.58	$214,500.00	161,819
5/31/2023	Tina Marriott Larson	COO	Sell	3,000	$8.63	$25,890.00	424,160
5/30/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,540,747
5/16/2023	Blake Borgeson	Director	Sell	8,885	$5.09	$45,224.65	7,549,632
5/3/2023	Christopher Gibson	CEO	Sell	33,073	$4.71	$155,773.83	953,225
4/18/2023	Blake Borgeson	Director	Sell	8,885	$5.93	$52,688.05	7,558,517
4/5/2023	Christopher Gibson	CEO	Sell	13,327	$6.46	$86,092.42	946,710
4/4/2023	Blake Borgeson	Director	Sell	8,885	$6.53	$58,019.05	7,567,402
3/21/2023	Blake Borgeson	Director	Sell	8,885	$7.40	$65,749.00	7,576,287
3/8/2023	Christopher Gibson	CEO	Sell	70,890	$8.10	$574,209.00	963,787
3/7/2023	Blake Borgeson	Director	Sell	8,885	$8.33	$74,012.05	7,585,172
3/2/2023	Christopher Gibson	CEO	Sell	18,500	$7.92	$146,520.00	940,927
2/27/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	52,500	$7.69	$403,725.00	12,869,423
2/23/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	51,864	$7.79	$404,020.56	12,707,805
2/23/2023	Tina Marriott Larson	COO	Sell	8,000	$7.82	$62,560.00	427,844
2/21/2023	Blake Borgeson	Director	Sell	8,885	$7.73	$68,681.05	7,594,057
2/21/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	94,418	$7.74	$730,795.32	12,605,000
2/16/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	42,682	$7.90	$337,187.80	12,447,200
2/15/2023	Shafique Virani	Insider	Sell	7,486	$8.33	$62,358.38	189,846
2/14/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	6,300	$7.95	$50,085.00	12,404,518
2/10/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	11,000	$7.98	$87,780.00	12,365,744
2/7/2023	Blake Borgeson	Director	Sell	8,885	$8.81	$78,276.85	7,602,942
1/26/2023	Tina Marriott Larson	COO	Sell	8,000	$8.07	$64,560.00	203,654
1/25/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	24,526	$7.88	$193,264.88	12,346,258
1/24/2023	Blake Borgeson	Director	Sell	8,885	$8.71	$77,388.35	7,611,827
1/17/2023	Shafique Virani	Insider	Sell	10,000	$9.16	$91,600.00	73,160
1/10/2023	Blake Borgeson	Director	Sell	8,885	$7.69	$68,325.65	7,620,712
1/9/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	76,046	$7.64	$580,991.44	12,252,214
1/5/2023	Christopher Gibson	CEO	Sell	18,500	$7.39	$136,715.00	525,805
1/5/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	80,035	$7.38	$590,658.30	12,107,215
1/3/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	141,646	$7.50	$1,062,345.00	11,935,288
12/29/2022	Tina Marriott Larson	COO	Sell	8,000	$7.70	$61,600.00	203,654
12/27/2022	Blake Borgeson	Director	Sell	8,885	$7.25	$64,416.25	7,628,272
12/15/2022	Shafique Virani	Insider	Sell	10,000	$8.85	$88,500.00	78,160
12/13/2022	Blake Borgeson	Director	Sell	8,885	$8.96	$79,609.60	7,637,157
12/1/2022	Christopher Gibson	CEO	Sell	37,210	$9.02	$335,634.20	582,805
11/29/2022	Blake Borgeson	Director	Sell	8,885	$8.75	$77,743.75	7,646,042
11/17/2022	Tina Marriott Larson	COO	Sell	16,000	$10.96	$175,360.00	203,654
11/16/2022	Blake Borgeson	Director	Sell	17,770	$11.12	$197,602.40	7,654,927
11/15/2022	Shafique Virani	Insider	Sell	10,000	$12.31	$123,100.00	83,160
11/3/2022	Christopher Gibson	CEO	Sell	36,693	$10.00	$366,930.00	576,016
10/27/2022	Tina Marriott Larson	COO	Sell	16,000	$10.72	$171,520.00	205,107
10/14/2022	Shafique Virani	Insider	Sell	10,000	$10.92	$109,200.00	88,773
10/6/2022	Christopher Gibson	CEO	Sell	36,053	$11.58	$417,493.74	562,959
9/29/2022	Tina Marriott Larson	COO	Sell	16,000	$10.86	$173,760.00	205,107
9/15/2022	Shafique Virani	Insider	Sell	10,000	$13.36	$133,600.00	93,773
8/16/2022	Shafique Virani	Insider	Sell	30,000	$12.61	$378,300.00	98,773
8/16/2022	Tina Marriott Larson	COO	Sell	16,000	$12.60	$201,600.00	295,107
8/4/2022	Christopher Gibson	CEO	Sell	36,825	$9.49	$349,469.25	541,829
7/7/2022	Christopher Gibson	CEO	Sell	37,114	$9.05	$335,881.70	528,904
6/2/2022	Christopher Gibson	CEO	Sell	39,690	$6.09	$241,712.10	516,268
5/4/2022	Christopher Gibson	CEO	Sell	31,830	$6.49	$206,576.70	511,972
4/28/2022	Christopher Gibson	CEO	Sell	37,605	$6.09	$229,014.45	469,608
4/21/2022	Christopher Gibson	CEO	Sell	37,155	$6.31	$234,448.05	420,146

See Full Table

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

89.06% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2025	San Luis Wealth Advisors LLC	10,150	$54K	0.0%	N/A	0.003%
4/17/2025	QRG Capital Management Inc.	28,515	$0.15M	0.0%	+8.5%	0.007%
4/17/2025	Mason & Associates Inc	33,165	$0.18M	0.0%	N/A	0.008%
4/17/2025	Exchange Traded Concepts LLC	18,624	$99K	0.0%	-63.3%	0.005%
4/16/2025	Wealth Enhancement Advisory Services LLC	24,230	$0.13M	0.0%	+27.8%	0.006%
4/16/2025	Azzad Asset Management Inc. ADV	16,811	$89K	0.0%	+21.6%	0.004%
4/15/2025	Integrated Advisors Network LLC	20,603	$0.11M	0.0%	+17.1%	0.005%
4/15/2025	SG Americas Securities LLC	162,068	$0.86M	0.0%	+228.5%	0.040%
4/15/2025	GAMMA Investing LLC	7,224	$38K	0.0%	+39.0%	0.002%
4/9/2025	Green Alpha Advisors LLC	178,873	$0.95M	1.0%	+166.4%	0.044%
4/8/2025	Rhumbline Advisers	359,175	$1.90M	0.0%	+7.5%	0.089%
4/7/2025	GAMMA Investing LLC	38,215	$0.20M	0.0%	+635.2%	0.010%
3/24/2025	Wellington Management Group LLP	114,945	$0.78M	0.0%	+9.5%	0.029%
3/18/2025	California State Teachers Retirement System	231,535	$1.57M	0.0%	+30.7%	0.058%
3/17/2025	Wealth Enhancement Advisory Services LLC	18,952	$0.13M	0.0%	N/A	0.005%
2/25/2025	Integrated Advisors Network LLC	17,588	$0.12M	0.0%	+36.8%	0.005%
2/19/2025	GF Fund Management CO. LTD.	8,016	$54K	0.0%	N/A	0.002%
2/18/2025	CSS LLC IL	54,093	$0.37M	0.0%	N/A	0.014%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,259,178	$15.27M	0.0%	+5.5%	0.578%
2/17/2025	Vident Advisory LLC	11,772	$80K	0.0%	N/A	0.003%
2/17/2025	Squarepoint Ops LLC	80,421	$0.54M	0.0%	N/A	0.021%
2/17/2025	Two Sigma Advisers LP	451,745	$3.05M	0.0%	-7.8%	0.116%
2/17/2025	Two Sigma Investments LP	1,660,509	$11.23M	0.0%	+4.0%	0.425%
2/17/2025	Sherbrooke Park Advisers LLC	26,230	$0.18M	0.1%	N/A	0.007%
2/17/2025	Softbank Group CORP.	14,667,491	$99.15M	0.4%	N/A	3.754%
2/17/2025	Rafferty Asset Management LLC	595,472	$4.03M	0.0%	-11.9%	0.152%
2/17/2025	Raiffeisen Bank International AG	150,000	$1.02M	0.0%	N/A	0.038%
2/17/2025	ProShare Advisors LLC	88,158	$0.60M	0.0%	+43.8%	0.023%
2/17/2025	Man Group plc	70,802	$0.48M	0.0%	N/A	0.018%
2/17/2025	Nuveen Asset Management LLC	1,069,950	$7.23M	0.0%	-4.8%	0.274%
2/17/2025	Millennium Management LLC	28,310	$0.19M	0.0%	-59.8%	0.007%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	165,062	$1.12M	0.0%	+5.1%	0.042%
2/17/2025	Lazard Asset Management LLC	555,850	$3.76M	0.0%	-13.5%	0.142%
2/17/2025	Laurion Capital Management LP	2,457,189	$16.61M	0.3%	N/A	0.629%
2/17/2025	Ensign Peak Advisors Inc	410,286	$2.77M	0.0%	+0.3%	0.105%
2/17/2025	Fullcircle Wealth LLC	16,155	$0.11M	0.0%	N/A	0.004%
2/17/2025	Deutsche Bank AG	217,723	$1.47M	0.0%	+53.6%	0.056%
2/17/2025	Cresset Asset Management LLC	25,029	$0.17M	0.0%	-64.6%	0.006%
2/17/2025	Casdin Capital LLC	165,323	$1.12M	0.1%	N/A	0.042%
2/17/2025	Cetera Investment Advisers	61,833	$0.42M	0.0%	+28.6%	0.016%
2/17/2025	Brevan Howard Capital Management LP	40,091	$0.27M	0.0%	N/A	0.010%
2/17/2025	Bayesian Capital Management LP	66,900	$0.45M	0.1%	N/A	0.017%
2/17/2025	Bellevue Group AG	377,806	$2.55M	0.0%	-3.8%	0.097%
2/17/2025	Benjamin Edwards Inc.	158,994	$1.08M	0.0%	-2.1%	0.041%
2/17/2025	BNP Paribas Financial Markets	34,504	$0.23M	0.0%	N/A	0.009%
2/17/2025	Ameriprise Financial Inc.	91,670	$0.62M	0.0%	+46.4%	0.023%
2/14/2025	Mercer Global Advisors Inc. ADV	25,624	$0.17M	0.0%	-11.4%	0.007%
2/14/2025	Novo Holdings A S	10,114,633	$68.38M	4.1%	N/A	2.589%
2/14/2025	RA Capital Management L.P.	7,725,096	$52.22M	0.7%	-49.8%	1.977%
2/14/2025	Schonfeld Strategic Advisors LLC	54,511	$0.37M	0.0%	N/A	0.014%
2/14/2025	Northern Trust Corp	2,394,511	$16.19M	0.0%	+18.4%	0.613%
2/14/2025	Susquehanna Fundamental Investments LLC	130,443	$0.88M	0.0%	N/A	0.033%
2/14/2025	Syon Capital LLC	23,456	$0.16M	0.0%	N/A	0.006%
2/14/2025	Price T Rowe Associates Inc. MD	131,990	$0.89M	0.0%	+17.4%	0.034%
2/14/2025	Hsbc Holdings PLC	36,339	$0.25M	0.0%	+48.2%	0.009%
2/14/2025	Stifel Financial Corp	159,887	$1.08M	0.0%	-1.3%	0.041%
2/14/2025	MetLife Investment Management LLC	149,808	$1.01M	0.0%	+9.7%	0.038%
2/14/2025	Nan Fung Group Holdings Ltd	664,610	$4.49M	3.8%	N/A	0.170%
2/14/2025	Dimensional Fund Advisors LP	1,708,040	$11.55M	0.0%	-0.6%	0.437%
2/13/2025	NewEdge Advisors LLC	7,847	$53K	0.0%	+43.7%	0.002%
2/13/2025	Jump Financial LLC	13,494	$91K	0.0%	N/A	0.003%
2/13/2025	Guggenheim Capital LLC	143,057	$0.97M	0.0%	-7.8%	0.037%
2/13/2025	Carroll Investors Inc	246,985	$1.67M	0.9%	+51.8%	0.063%
2/13/2025	XTX Topco Ltd	83,547	$0.57M	0.0%	N/A	0.021%
2/13/2025	CreativeOne Wealth LLC	18,368	$0.12M	0.0%	N/A	0.005%
2/13/2025	Mariner LLC	111,063	$0.75M	0.0%	+32.9%	0.028%
2/13/2025	Barclays PLC	633,125	$4.28M	0.0%	-9.2%	0.162%
2/13/2025	Summit Investment Advisors Inc.	26,030	$0.18M	0.2%	+7.8%	0.007%
2/13/2025	Rockefeller Capital Management L.P.	281,922	$1.91M	0.0%	+323.1%	0.072%
2/13/2025	Jaffetilchin Investment Partners LLC	21,754	$0.15M	0.0%	N/A	0.006%
2/13/2025	Zuckerman Investment Group LLC	34,000	$0.25M	0.0%	-15.0%	0.009%
2/13/2025	Capital Fund Management S.A.	183,796	$1.24M	0.0%	N/A	0.047%
2/13/2025	Raymond James Financial Inc.	90,107	$0.61M	0.0%	N/A	0.023%
2/13/2025	Advisory Services Network LLC	10,947	$74K	0.0%	N/A	0.003%
2/13/2025	Rathbones Group PLC	10,145	$69K	0.0%	N/A	0.003%
2/13/2025	Legal & General Group Plc	253,426	$1.71M	0.0%	+26.7%	0.065%
2/13/2025	Invesco Ltd.	178,619	$1.21M	0.0%	+54.6%	0.046%
2/13/2025	Titleist Asset Management LLC	23,065	$0.16M	0.0%	-40.6%	0.006%
2/13/2025	Russell Investments Group Ltd.	196,652	$1.33M	0.0%	-17.4%	0.050%
2/13/2025	Envestnet Asset Management Inc.	231,756	$1.57M	0.0%	+5.3%	0.059%
2/13/2025	Wells Fargo & Company MN	458,321	$3.10M	0.0%	+298.5%	0.117%
2/12/2025	Thoroughbred Financial Services LLC	10,000	$67K	0.0%	-33.3%	0.003%
2/12/2025	Headlands Technologies LLC	89,314	$0.60M	0.1%	+196.7%	0.023%
2/12/2025	Geode Capital Management LLC	6,087,149	$41.16M	0.0%	+12.1%	1.558%
2/12/2025	Franklin Resources Inc.	75,779	$0.51M	0.0%	+299.6%	0.019%
2/12/2025	Alliancebernstein L.P.	243,214	$1.64M	0.0%	+11.9%	0.062%
2/12/2025	Pier 88 Investment Partners LLC	161,730	$1.09M	0.2%	+20.8%	0.041%
2/12/2025	Wellington Management Group LLP	114,945	$0.78M	0.0%	+9.5%	0.029%
2/12/2025	Schroder Investment Management Group	11,876	$88K	0.0%	-22.4%	0.003%
2/12/2025	DnB Asset Management AS	85,365	$0.58M	0.0%	N/A	0.022%
2/12/2025	Pictet Asset Management Holding SA	35,397	$0.24M	0.0%	+58.5%	0.009%
2/12/2025	Norges Bank	3,465,875	$23.43M	0.0%	N/A	0.887%
2/12/2025	Blair William & Co. IL	12,000	$81K	0.0%	N/A	0.003%
2/12/2025	IQ EQ FUND MANAGEMENT IRELAND Ltd	200,470	$1.36M	0.2%	+143.4%	0.051%
2/12/2025	JPMorgan Chase & Co.	1,057,167	$7.15M	0.0%	-10.1%	0.271%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	28,277	$0.19M	0.0%	+38.8%	0.007%
2/11/2025	Corebridge Financial Inc.	123,705	$0.84M	0.0%	-3.0%	0.032%
2/11/2025	Vanguard Group Inc.	34,009,994	$229.91M	0.0%	+40.1%	8.704%
2/11/2025	LPL Financial LLC	367,785	$2.49M	0.0%	+2.0%	0.094%
2/11/2025	Fox Run Management L.L.C.	31,078	$0.21M	0.0%	N/A	0.008%

Data available starting January 2016

See Full Table

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $5.63

$5.46

$5.70

50 Day Range

MA: $6.56

$3.97

$10.87

52 Week Range

Now: $5.63

$3.79

$12.36

Volume

8,065,755 shs

Average Volume

12,064,898 shs

Market Capitalization

$2.26 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Tina Marriott (COO)
Tina Marriott Larson (COO)
Dean Y Li (Director)
Shafique Virani (Insider)
Terry-Ann Burrell (Director)
Zavain Dar (Director)
Learn More about top insider investors at Recursion Pharmaceuticals.
Who are the major institutional investors of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top institutional investors include:
Rhumbline Advisers — 0.09%
IMC Chicago LLC — 0.00%
Green Alpha Advisors LLC — 0.04%
SG Americas Securities LLC — 0.04%
GAMMA Investing LLC — 0.01%
Mason & Associates Inc — 0.01%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.
Which institutional investors are selling Recursion Pharmaceuticals stock?: Within the previous quarter, RXRX stock was sold by these institutional investors:
Exchange Traded Concepts LLC
During the last year, company insiders that have sold Recursion Pharmaceuticals company stock include:
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Tina Marriott (COO)
Learn More investors selling Recursion Pharmaceuticals stock.
Which institutional investors are buying Recursion Pharmaceuticals stock?: In the previous quarter, RXRX stock was purchased by institutional investors including:
IMC Chicago LLC
SG Americas Securities LLC
Green Alpha Advisors LLC
Mason & Associates Inc
GAMMA Investing LLC
Rhumbline Advisers
San Luis Wealth Advisors LLC
Wealth Enhancement Advisory Services LLC